发明授权
- 专利标题: Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof
- 专利标题(中): 口服HMG-CoA还原酶抑制剂的缓释制剂及其制备方法
-
申请号: US10599729申请日: 2005-04-08
-
公开(公告)号: US08475840B2公开(公告)日: 2013-07-02
- 发明人: Jong Soo Woo , Hong-Gi Yi , Moon-Hyuk Chi , Jae-Kuk Ryu , Si-Young Jung , Yong-Il Kim
- 申请人: Jong Soo Woo , Hong-Gi Yi , Moon-Hyuk Chi , Jae-Kuk Ryu , Si-Young Jung , Yong-Il Kim
- 申请人地址: KR Hwaseong-si
- 专利权人: Hanmi Science Co., Ltd
- 当前专利权人: Hanmi Science Co., Ltd
- 当前专利权人地址: KR Hwaseong-si
- 代理机构: Sughrue Mion, PLLC
- 优先权: KR10-2004-0024734 20040410
- 国际申请: PCT/KR2005/001021 WO 20050408
- 国际公布: WO2005/097194 WO 20051020
- 主分类号: A61K47/00
- IPC分类号: A61K47/00
摘要:
The sustained release formulation for oral administration of an HMG-CoA reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs. Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
公开/授权文献
信息查询